BeyondSpring

$20.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-1.57%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BeyondSpring and other stocks, options, ETFs, and crypto commission-free!

About BYSI

BeyondSpring Inc. Ordinary Shares, also called BeyondSpring, is a clinical stage company, which engages in the development of cancer therapies. Read More It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

Employees
52
Headquarters
New York, New York
Founded
2013
Market Cap
522.14M
Price-Earnings Ratio
Dividend Yield
Average Volume
47.25K
High Today
$20.74
Low Today
$19.72
Open Price
$20.71
Volume
73.50K
52 Week High
$26.86
52 Week Low
$13.06

Collections

BYSI Earnings

-$0.73
-$0.59
-$0.46
-$0.32
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.58 per share
Actual
-$0.32 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.